The Rinaldi Fontani Institute is a health care, research and training Institution in the field of epigenetic disorders and diseases.
Epigenetics studies the changes induced in our body by many environmental factors, such as our lifestyles, nutrition, substances with which we come into contact, type of work, chronic stress.
With the aim of studying in detail the epigenetic disorders and diseases, Salvatore Rinaldi and Vania Fontani, medicine doctors and founders of the Institute, have conceived and developed the Radio Electric Asymmetric Conveyer (REAC) Technology.
The REAC technology is an innovative medical technology designed specifically to allow new therapeutic methods of Bio and Neuro modulation in the ambit of epigenetic pathologies.
The most common epigenetic diseases in biology are: alterations in metabolic control, chronic diseases of various organ systems (cardiovascular, endocrine, immune and skeletal muscle) and disorders related to aging.
The most common epigenetic diseases in neurological and psychiatric field are: psychiatric diseases, neurological development disorders, neurodegenerative diseases, particularly those associated with aging such as Alzheimer's, Parkinson's and senile dementia.
The REAC technology effects are well established and documented in numerous scientific papers published in prestigious scientific journals indexed in PubMed.